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 DRUGS IN SPORT:  
A Study of the Origins, Rights and Outcomes 
 
 
ANNETTE GREENHOW * 
 
 
1. INTRODUCTION 
 
Rarely a day goes by when a story doesn’t appear in the local newspaper involving the use of 
drugs in sport and an allegation of an anti-doping offence against an athlete.   It is almost a ‘watch 
this space’ approach during or shortly following a world sporting competition to see whether drug 
cheats have been caught in the World Anti-Doping Agency (WADA) web of testing.1 
In the 1980’s, commentators declared, “Unless something is done soon, international sport will be 
a competition between circus freaks manipulated by international chemists”.’2 Fast-forward to 
2009, and the picture is not quite as bleak as the earlier prediction, but the issue of drugs in sport 
remains a topical issue in the sporting world today.   
Athletes are continually becoming bigger, stronger and faster, and are raising the level of 
performance in their sport.   The most recent World Athletics Championships in Berlin produced 
some stunning records but also some revelations of the positive testing of Jamaican runners, 
Yohan Blake and Marvin Anderson.3   Without being blinded by the drug use allegations, it is 
necessary to consider the fact that training regimes, diet, and sporting technique and equipment 
are all continually developing and also play an important role in athletic performance. 
As such, few topics provoke as much emotional intensity as the issue of the use of drugs in sport.4 
At one end of the spectrum, the regulator5 whose role is to preserve the spirit of the sport6 and act 
as the paternalistic protector of the athlete, setting the moral high ground to meet community 
expectations.7  Closer to the other end sits the ‘artificial line in the sand’ view8 that drugs in sport 
are no different to other performance enhancing tools developed with the aid of technological 
advances, or such other techniques that involve following a special diet or particular training 
regime.9   
At the extreme end of the spectrum is the argument in favour of allowing ‘safe’ performance 
enhancing drugs in sport to create a more level playing field.10  But what often gets overlooked for 
a headline grab, is that what was originally designed to stop drug cheats using artificial 
performance enhancers in Olympic competition,11 has now been extended to cover the use of 
recreational drugs outside competition in the context of the private life of an athlete, carrying 
sanctions and bans from competition that can have a significant economic impact on the relatively 
short career span of an athlete.12     
 This paper will examine the origins of the use of drugs in sport, dating back to ancient times 
through to modern evidence in the broader context of recreational and performance enhancing 
drug use.  It will also consider the rights of the athlete involved in an anti-doping offence and 
examine whether the protection of the legitimate interests of the sport is still sufficient to justify the 
imposition of the strict liability principles applicable today. One perspective that requires further 
examination is whether the ‘one rule fits all’ approach to the application of the sanctions under the 
WADA Code is reasonable or whether they could amount to a restraint of trade in certain cases, 
either at common law or in contravention of provisions of the Australian Trade Practices Act 1974 
(Cth) (TPA).  
This paper also considers whether the business of sport has evolved to such an extent as to attract 
the attributes of other commercial entities - forming part of a trading society13 and whether the 
sanctions truly reflect societal views as acceptable and still necessary in modern times.  
2. ORIGINS OF DOPING 
2.1 Enhancing Performance in Ancient Times 
So, when did it all begin?  References to stimulants in sport were seen as far back as 77-79AD 
when Naturalist, Galus Plinius Secundus (Pliny the Elder) completed his writings, Naturalis Historia 
14, and referred to the use of the horsetail plant as a stimulant for long distance runners. Many of 
this early evidence focussed on the Olympics in Greece.  
In ancient times, Greek athletes were idolised much in the same way as athletes are today, largely 
due to their belief that they descended from the Gods, possessing equal strength and stamina in a 
culture obsessed with the athletic physique and physical prowess.15  The stakes were high and the 
incentives great.  A victorious Greek Olympian was often paid handsomely. 16 Success could 
attract a windfall of around today’s equivalent of £500,000 17in addition to tax exemptions, housing, 
and several other rewards.18   
Performance enhancement in ancient times largely involved the use of plant or animal stimulants 
as a source of mental and/or physical enhancement, with varying degrees of effectiveness.     One 
example recorded an athlete devouring nothing but dried figs, going on to win the sprinting event at 
the Olympic Games in 660 BC.19 Similar attempts were made to enhance performance by following 
diets ranging from wrestlers consuming excessive amounts of lamb20, to other Greek athletes 
using hallucinogenic mushrooms for mental preparation.21 Others were reputed to have consumed 
exotic ‘potions’ of herbs and seeds bearing stimulant properties.22 While the effectiveness of these 
techniques is debatable, the foundation was laid for the use of performance enhancing 
‘substances’ and a ‘win at all costs’ mentality to gain a competitive advantage over others in the 
sport. This aspect of the competition of sport laid the foundations for today’s sophisticated drug 
enhancement practices. 
 
 2.2 The Evolution of ‘Doping’ 
The practices in ancient times resemble what we now know as ‘doping‘.   However the label did not 
develop until the mid 1800’s when horse trainers would use opium and narcotics to dope 
racehorses. 23  The word doping itself is derived from the word ‘dop’, first used in South African 
dialect to describe the practice of using potent alcoholic drinks in religious cult scenes.24  
Scientific studies were conducted in 1876 by Sir Robert Christison, who published his self-
conducted experiments on the advantages of using the Peruvian coca leaf as a means of fighting 
fatigue during exercise.25  Shortly thereafter, in 1879, the first incident of doping in sport emerged 
in the 6-day cycling event where cyclists were known to have consumed a combination of caffeine, 
alcohol, nitroglycerine, and cocaine to overcome the rigorousness of the event.26    
2.3 Use of Anabolic Steroids  
The beginning of the 20th century saw a noticeable increase in the efforts to gain the competitive 
edge. The most well known case of drug use in early Olympic sport occurred at the St. Louis 
Olympics of 1904, where American marathon runner Thomas Hicks won his event, only to collapse 
at the conclusion of the race. Upon investigation, Hicks’ support team admitted to providing him 
with brandy and the potent stimulant strychnine throughout the race as they followed alongside 
him.   The combination of the two substances, which nearly killed him, masked the fatigue from the 
marathon and the effects of the hot and humid weather conditions.27   As a testament to the early 
competitive mentality and its connection with performance enhancement, Hicks, who was not 
stripped of his medal, went on to state that he would “rather have won this race than be president 
of the United States.”28  
The period between 1930 and 1950 saw the development of a variety of uses for testosterone. 
This came about largely as a result of enhanced testing facilities and the discovery of the affects of 
testosterone by increasing muscle tone, sexual enhancements and productivity.29  During the 
1950’s the use of anabolic steroids was first detected in Olympic Sport when the Soviet 
weightlifters were believed to have used steroids. 30  By 1958, Dianabol had been synthesised in 
the United States and the orally ingested Turinabol had been synthesised in East Germany after 
1966, ultimately leading to the wider use of steroids.  
From the mid-1960‘s, the use of steroids was so popular that the era became described by some 
commentators as the start of the “virilization” of sport.31   In 1969, some athletes were so brazen 
about their performance enhancing techniques that they would openly boast about the 
effectiveness of the steroids they were taking.32   
The existence of ‘super labs’, responsible for the design, testing and supply to athletes of modern 
performance enhancing substances came to prominence in 2003 with the much publicised 
investigation into the Bay Area Laboratory Co-Operative (BALCO) in the United States. Several top 
American athletes were implicated and were later suspended from competition. 33  The most 
sensational fallout was that of Marion Jones, the former track and field world champion, who 
 admitted in 2007 (after having denied involvement for many years earlier) of steroid use before the 
2000 Sydney Olympic Games.  Jones was stripped of her medals, suspended for 2 years, and 
jailed for perjury for 6 months.34 
2.4 Amphetamines 
The use of amphetamines was on the increase from the mid 1930‘s35.   Cyclists were known for 
their amphetamine use and the death from overuse in 1967 of cyclist Tom Simpson during in the 
Tour de France highlighted the extent of its use in cycling. 36    But the use of amphetamines in 
other sports was also gaining momentum.  In the 1960’s, testing of Italian football players resulted 
in 36% of the players tested showing signs of having taken amphetamines prior to games.37  
2.5 Blood Doping Techniques and EPO 
Around the same time as the increasing use of steroids and amphetamines, other performance 
enhancing techniques began to surface. Blood doping and blood transfusions were techniques 
allegedly used by European distance runners, cyclists, cross-country skiers and biathletes as early 
as 1971.38  The Soviets were known to have engaged in extensive government-funded research 
on blood doping in the 1970’s.39  Other countries involved in such research originally denied their 
involvement.  However, 14 years after the 1976 Montreal Olympics, results from blood doping 
studies conducted on Soviet athletes were released, confirming the large research endeavours 
that had been undertaken.40   
The development and studies conducted in the 1980’s on the hormone erythropoietin (EPO) and 
the discovery of its affect on the regulation of red blood cell mass and oxygen delivery lead to an 
increase in use in endurance sports. In more recent times, EPO has been detected in sports 
ranging from long-distance speed skaters and skiers at the 2002 Salt Lake City Winter Olympics 
(where EPO was heralded as the ‘drug of choice’41) to the more passive sport of billiards. 42    
2.6 Growth Hormone 
The 1980’s saw the developing use of growth hormone (GH), by athletes, long before it was known 
for its therapeutical benefits.43  GH is used for its anabolic effects and is difficult to detect, leading 
to an increase in its use.  GH use has been detected in a number of sports in recent times, 
including the NFL in the United States. 44 
2.7  Recreational Drugs 
While the study of the history of drug use in sport has predominantly involved considerations of the 
evolution of drug development, a more recent trend has been to include ‘recreational’ drugs used 
outside competition.  
There is a long history of recreational drug use in sport dating back to the use of hallucinogenic 
mushrooms by ancient Greek athletes for psychological preparation. Indeed, it is generally for their 
 psychological effects that recreational drugs are used; recreational drugs may reduce anxiety and 
allow for better concentration, and allow for the relaxation of limb movement.45  It is for these 
reasons that many view such drugs as providing an unfair advantage.  However, studies on 
cannabis have shown that the drug impairs cognition and psychomotor and exercise performance.  
Therefore, its psychological effects and the gaining of a competitive advantage are questionable.46  
Preserving the ‘spirit of the sport’ may be the justification for including recreational drugs on the 
WADA Prohibited List. 
Considering the evolution of drugs in sport and the more recent concern of increased recreational 
drug use, a further point can be raised that the number of athletes using recreational drugs 
including cannabis appears to be increasing.47  One can hypothesise that this increased detection 
in athletes coincides with the drug culture of the 21st century.  It is also necessary to consider 
whether this may also be a result of an increase in the pressures and anxieties that are attached to 
sports in today’s society.  Whatever its cause, recreational drug use of well known athletes such as 
Michael Phelps, Ben Cousins and others in recent times has been an issue of growing concern 
and has changed the face of the traditional drug use in sport debate. 48 
2.8 Gene Doping 
Some have suggested that human body will soon reach a plateau where it is no longer capable of 
further extensive physiological enhancement and there is less room for further physiological 
improvement in athletes.49  
However, the possibilities of new technologies such as gene doping are emerging in the sporting 
context. Gene modification has been shown to alter muscle performance in animals in laboratory 
experiments, and research continues to be conducted on the potential uses of gene therapy in 
humans.50 The WADA Prohibited List 2009 currently specifies Gene Doping in the following terms: 
The transfer of cells or genetic elements or the use of cells, genetic elements or 
pharmacological agents to modulating expression of endogenous genes having the 
capacity to enhance athletic performance.51 
Note that the 2008 Prohibited List referred to Gene Doping as: 
 The non-therapeutic use of cells, genes, genetic elements, or of the modulation of 
gene expression, having the capacity to enhance athletic performance, is prohibited.  
52 
Since ancient times, athletes have looked for ways to gain a competitive edge over the opposition. 
Emerging techniques and technologies may simply be considered an aspect that has become an 
unavoidable part of sport that seems to be here to stay.   
3. ORIGINS OF DRUG TESTING 
 3.1 The Olympic Movement Anti-Doping Code (OMADC) 
Not surprisingly, the evolution of drug testing has coincided with the development and increase in 
the use of drugs in sport.   The first co-ordinated testing efforts to detect the presence of anabolic 
steroids was performed by the International Olympic Committee (IOC) at the Montreal Olympics 
1976, although many sporting bodies in non-Olympic sports had anti-doping rules in place and 
testing procedures to enforce their particular rules. 
However, it was the IOC that took charge of the anti-doping program at an international level. This 
was done through the development of the OMADC, which applied to the Olympic Games, World 
Championships and those sports competing in Olympic competition. The OMADC contained the 
anti-doping rules for the IOC and in many ways, supplied the template for the WADA code and 
international standards now in place today.53 
While the OMADC went some way to bring the anti-doping regimes under the one umbrella, there 
were many examples of inconsistent application to those sports that fell outside the umbrella and 
applied their own anti-doping rules and regulations to their particular sport.  Due to the diverse 
nature of sport, both at a local, national and international level, it was not surprising that there were 
different approaches to the regulation of the various anti-doping regimes.   
But it was the scandal in the 1998 Tour de France involving the Festina cycling team54 that 
provided the impetus for a more co-ordinated and harmonised approach to the regulation of the 
anti-doping regime.  
3.2   The World Anti-Doping Authority - WADA  
The World Anti-Doping Authority (WADA) will celebrate its 10th anniversary in November 2009, 
having been established in 1999 to ‘promote, co-ordinate and monitor the fight against doping in 
sport internationally.’55  A period of consultation followed leading to the unanimous acceptance of 
the Code at the World Conference on Doping held at Copenhagen in March 2003.56   
In 2004, the WADA Code was introduced and outlined the WADA program for the promotion, co-
ordination and regulation of the anti-doping regime.  There has almost been universal acceptance 
by sporting federations of the WADA Code, 57 which has the effect of filtering down to the local 
level by ensuring that membership to the particular sporting organisation binds the individual 
participant to the agreement to the Code. The Code contains core articles and non-core articles. 
Sporting organisations that accept the Code are required to implement the core articles and agree 
to promote the non-core articles in their handling of anti-doping matters within their particular 
sports. 58      
WADA is responsible for the preparation and publication of The Prohibited List which outlines the 
International Standard that identifies substances and methods prohibited in-competition, out-of-
competition, and in particular sports.  The substances and methods are classified by categories 
 (e.g., steroids, stimulants, gene doping).  The List is updated annually and determined by the List 
Committee, a panel of scientists chosen for their international experience.59   
The harmonisation of the anti-doping regime has certainly resulted in a significant increase in the 
number of testing procedures undertaken and the subsequent detection of performance enhancing 
drugs in sport over the past five years. 60 
4. RIGHTS OF ATHLETES 
4.1  Challenges 
Limited opportunities arise under the Code for an athlete to challenge an anti-doping violation, 
mainly due to the strict liability principles that apply and the presumed guilt of the athlete when the 
presence of a prohibited substance is identified from a collected sample. 
Challenges are initially made to the relevant sporting tribunal for the sport involved.  If dissatisfied 
with the outcome, an appeal can be lodged to the Court of Arbitration of Sport (CAS), an 
alternative method of dispute resolution involving a panel of members vested with powers to make 
final and binding decisions.   
The jurisdiction of the CAS requires the agreement of the parties to refer disputes to it and the 
scope of its powers are contained within the Code to apply sports related arbitration in both original 
and appellate jurisdiction. 
A significant number of appeals to the CAS centre around the question of whether or not the anti-
doping regime and the imposition of the mandatory sanctions interferes with the fundamental 
principles of human rights applicable in a particular jurisdiction. 
4.2 The Strict Liability Principle and the Standard and Burden of Proof 
The strict liability principle in relation to the anti-doping regime means that an athlete could be 
liable without fault, and based on the fact of the presence of a prohibited substance in the collected 
samples. Regardless of how the substance came to be, and regardless of any intention to cheat, 
an athlete is guilty of a doping offence. 
The burden of proving the presence of a prohibited substance rests with the organisation bringing 
the allegation.  If the organisation bringing the allegation discharges this burden, strict liability 
results in a presumption that a doping offence had been committed. 
This reversal of the usual onus of proof that exists in the criminal jurisdiction is argued to be 
justified on the basis that it would be impossible for the sporting organisation to prove intent and 
that it lacks the coercive authority to force investigations.61 The standard of proof is lower than the 
criminal standard but higher than the ordinary civil standard. It is expressed to be a standard 
established to the comfortable satisfaction of the CAS bearing in mind the seriousness of the 
allegation made.62    
 This is perhaps one feature of the entire regime that continues to raise issues as to fairness.  
Where the wording of the Code is clear in regard to the anti-doping violation, the strict liability test 
will prevail. In such cases, the unfairness to the athlete found to have inadvertently absorbed a 
prohibited substance will be subordinate to the rights and expectations of the other competitors 
and the community. 
4.3 Sanctions and Penalties 
The Code prescribes the fixed periods of suspension and consequences of an anti-doping offence.  
The Code was recently amended in 2009 to provide a degree of flexibility from the earlier 
mandatory two-year suspension period.  The 2009 amendments seem to have been made against 
the background of the numerous arguments previously raised about the interference with the 
fundamental rights of the athlete.  A careless athlete who had no intention to cheat or enhance 
performance was dealt with in the same way as a deliberate athlete using performance-enhancing 
drugs with the sole motivation of cheating. 
The CAS in deciding the relevant suspension period can now take a range of facts into account.63  
The onus of proof rests with the athlete to produce evidence to support the reasons as to how the 
specified substance entered his or her body and to establish the absence of intent or intention to 
enhance sporting performance to the higher standard required by the CAS.  
4.4 Restraint of Trade 
Challenges have been mounted against the Code based on a number of key principles involving 
the interference with the athlete’s right to work, right to privacy, and right to not be unfairly 
discriminated against.  One of the prevailing arguments in this area is that the imposition of the 
strict liability test and the suspension periods are unreasonable and breach the doctrine of restraint 
of trade. 
A restraint of trade is an interference with an individual’s right to work, affecting his or her ability to 
earn an income.  All restraints are void as being contrary to public policy, unless the restraint is 
reasonable and justified as being in the public interest.64     
In ordinary commercial arrangements, a restraint of trade argument can arise between employers 
and employees, vendors and purchasers of a business with goodwill, and trading agreements 
between manufacturers and retailers.  In the sporting context, the question arises as to whether an 
athlete is in trade, and whether an athlete participates in a market where society will protect the 
athlete from unacceptable and unnecessary restrictions on the right to trade. 65  
In the case of a professional athlete, there are a number of commercial arrangements that may 
impose conditions that operate as a restraint of trade.   For example, an athlete’s contract of 
engagement with his or her club, an athlete’s agreement with the sporting organization responsible 
for the organizing of competitions, and the athlete’s agreement to abide by the rules of the 
 governing bodies of the sport at a local, state, national and international level including the anti-
doping specific rules imposed under the WADA Code66     
In the sporting context, the necessary economic link must exist between the rules of the sporting 
association to allowing the athlete to obtain income through sponsorship directly related to 
participation in events governed by the sporting associations.67 In such a case, the athlete is in 
trade, regardless of whether the athlete is professional or amateur.68 
A restraint of trade argument could be mounted if the consequence of a breach of the commercial 
arrangement is an unreasonable restriction on the athlete’s ability to carry on his or her ‘trade’.   
Central to the issue of whether the restraint is reasonable or not, is an analysis of the benefit to be 
derived by protecting the interests of sport, the club, the players and the public, as against the 
detriment likely to be suffered by the athlete and the consequent deprivation of earning capacity. 
4.5 Doping Sanctions as a Restraint of Trade 
In Gasser v Stinson69 the athlete argued that the International Amateur Athletics Federation (IAAF) 
rules were not binding, as they were an unreasonable restraint of trade.   Gasser was given an 
automatic ban after having a prohibited substance found in a urine sample.  She challenged the 
strict liability nature of the penalty and argued that the automatic ban was in fact a mandatory 
sentence, regardless of guilty intent.  It was argued that to treat those who fell into this category as 
if they were known cheats was unreasonable.70 
The Court considered that a suspension from competition could be regarded as restraint of trade.71  
However, the difficulty of proving moral innocence would ‘lead to an opening of the floodgates and 
the attempt to thwart drug taking would become futile’.72  The interests of the IAAF in imposing the 
sanction were to deter athletes from taking performance enhancing drugs and ensure a drug-free 
sport.  This was held to be a legitimate interest, sufficient to negate the restraint of trade argument. 
More recently, in Canas v ATP Tour,73 the CAS rejected the athlete’s argument that the rules 
imposing the sanction were in breach of the Sherman Antitrust Act.74   Canas was found to have 
taken a prohibited substance after unintentionally taking prescription drugs meant for another 
person. 
Even with the flexibility of the discretionary powers of the CAS in the 2009 Code, the question 
remains whether applying any sanction, without regard to mens rea75 is reasonable, and still 
acceptable and necessary. 76 
4.6 Unconscionable Conduct? 
It is worth considering whether the unconscionable conduct provisions of the Trade Practice Act 
could be relied upon by an athlete in a commercial arrangement where there is an inequality of 
bargaining power between the athlete and the club, organisation or governing body.   
 Section 51AC of the TPA prohibits a corporation from engaging in unconscionable conduct in 
commercial transactions. This section could potentially apply to contracts signed between young 
emerging athletes and sporting organisations.  A non-exhaustive list of factors can be taken into 
account in determining whether a corporation or person has engaged in unconscionable conduct.77  
In addition to the relative strength of the bargaining positions of the parties, a consideration of the 
conditions imposed by the corporation and whether these were necessary for the protection of its 
legitimate interests, and whether the other party was able to understand any documents relating to 
the supply of the services are also relevant.   The last factor in this list is the extent to which the 
supplier and business consumer acted in good faith.78 
The issue of conduct is relevant and should be examined in the context of s. 51AC if the athlete is 
regarded as the business consumer, and the club, organisation or governing body as the 
corporation (without the need to be a ‘trading corporation).   
The suggestion that there is a significant degree of ignorance surrounding the understanding of the 
anti-doping regime by athletes, coaches and advisors at national and international levels is cause 
for concern.79  The ‘take it or leave it’ approach to participation in an Olympic sport might raise 
arguments surrounding this conduct in the particular sporting context.  The whole issue of capacity 
to contract when a young athlete is drafted may also give rise to a consideration of the relative 
equality of bargaining positions of the parties and whether any issue of unconscionability is 
relevant at that point in time. 
4.7 Criminal Law Principles 
When considering the purpose of the sanctions, and the interests that are to be protected, Buti and 
Fridman80 draw a parallel between the sports context and the criminal law context and discuss 
underlying policy considerations in respect of imposing penalties on convicted criminals.81     They 
argue that the incarceration of convicted criminals (and the resultant loss of income) is acceptable 
to society as a reasonable way to protect the public.  They pose the question whether the same 
assumption could be made when dealing with athletes.     
It is outside the scope of this paper to consider the criminal law principles applicable to a drug 
offence.  However, the question remains as to how the anti-doping regime can depart so 
dramatically from criminal law principles involving the burden and standard of proof.  One of the 
explanations offered to justify the divergence is that the anti-doping regime is focused purely on 
the application and interpretation of the agreement between the athlete and the particular anti-
doping regime.82 Can the policy still support the strict liability principles and justify the reversal of 
Blackstone’s theory 83 in a sporting context - rather the morally innocent be punished to ensure that 
the guilty do not go free?84 
4.8 The Other End of the Spectrum - Allowing Certain Drugs in Sport 
A number of arguments have been advanced as to why some drugs that are known to have 
performance enhancing benefits should be allowed in sport.  Coinciding with the year the WADA 
Code was first implemented, the 2004 article “Why We Should Allow Performance Drugs In Sport” 
appeared in the British Journal of Sports Medicine.85 It outlined some compelling arguments 
warranting further consideration.  
 The arguments focussed on the fact that notwithstanding the known health risks and the stigma of 
being known as a drug cheat, the use of illegal substances is widely known to be rife in sport. The 
competitive advantage or ‘win at all costs’ mentality has prevailed and will continue to prevail.     
An economic argument was advanced that from a pure cost/benefit analysis, the economic 
benefits associated with success (in the form of prize money, sponsorship and endorsement) was 
so great compared to the relatively small penalties and suspension period, that cheating will 
continue.  In support of this, reference was made to the ‘Haugen’ model of sports economics which 
suggests that unless the likelihood of athletes being caught (the cost) was raised to unrealistically 
high levels, and the benefits for winning (the benefits) were reduced to unrealistically low levels, 
athletes will choose to cheat.86 
An interesting argument is also advanced from the health perspective and a consideration of the 
use of drugs in society generally in comparison to drug use in the sporting context.  It has been 
argued that the amount of money spent per drug user in the sporting context to enforce the anti-
doping regime far outweighs the amount spent on combating drugs in society, yet the problem in 
society is far greater than in sport. 
History suggests that when regulations seek to prohibit something already in demand, (e.g. alcohol 
during the Prohibition of the 1920’s) the likely effect is that the manufacture, supply and delivery of 
the substance goes underground. 87  The BALCO investigation may provide a modern example of 
this theory.88 
5. CONCLUSION 
It remains to be seen whether an athlete will be successful in mounting a restraint of trade or 
unconscionability argument against a doping sanction.  The introduction of the ‘discretionary’ 
powers in the 2009 WADA Code may provide greater flexibility and an opportunity for the sporting 
tribunal or the CAS to take into account the nuances of the particular case. 
In the case of doping sanctions imposed for the use of recreational drugs, arguments have been 
advanced to suggest that a restraint of trade claim would have stronger prospects of success on 
the basis of a weakening of the public policy justification for imposing the sanction. It will be 
interesting to see if the ‘trading society test’ could be advanced to permit a review on the basis that 
the business of sport has evolved to such an extent to question whether the sanctions imposed are 
still ‘acceptable and necessary’.    
Questions surrounding the relative equality of bargaining power in the ‘business‘ of sport   might 
one day give rise to an examination of the conduct of the parties and consideration of the 
unconscionability provisions of the Trade Practices Act.   
One thing remains - the motivation in 77AD for using the horse tail plant as a stimulant for long 
distance runners is no different to the motivation in modern times of the likes of Marion Jones, and 
unless we start to seriously embrace some ways of applying the ‘Haugen’ model and achieving a 
realistic balance between costs and benefits, the use of drugs in sport is here to stay. 
  
 
                                                 
* Assistant Professor, Bond University. Solicitor of the Supreme Court of Queensland.   With thanks to Mitchell Smith, 
Research Assistant from Bond University, Queensland, for his extensive research into the origins of drugs in sport and 
analysis of doping statistics and drug use.  
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